To access this element change to forms mode OFF
Grant Award View - GA205204
Prolonging survival in glioblastoma through quiescence inhibition
GA ID:
GA205204
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
3-Nov-2021
Publish Date:
13-Dec-2021
Category:
Medical Research
Grant Term:
1-Jan-2022 to 1-Jan-2025
Value (AUD):
$571,687.60
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Ideas Grants
Grant Activity:
Prolonging survival in glioblastoma through quiescence inhibition
Purpose:
Most people diagnosed with the brain cancer glioblastoma die within 15-months. The cancer is so deadly because it rapidly returns after therapy. Glioblastoma returns because of slowly dividing cancer stem cells that resist treatment. Our strategy is to eliminate these cells by forcing them to divide quickly during chemotherapy. This project will test targeted molecules in organoid and pre-clinical animal models of the disease to establish an evidence base for Phase 1 trials.
GO ID:
GO Title:
2021 Ideas Grants
Internal Reference ID:
2021/GNT2011595
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Council of the Queensland Institute of Medical Research
Recipient ABN:
31 411 813 344
Grant Recipient Location
Suburb:
Herston
Town/City:
Herston
Postcode:
4006
State/Territory:
QLD
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
ACT, QLD
Postcode:
Multiple
Country:
AUSTRALIA